A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
Manufactured by
Seoul, South Korea
GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Intelligenome
United States · 2 relevant products
Beijing SynsorBio Technology Co., Ltd
China · 3 relevant products
Guangzhou magigen biotechnology Co.,Ltd
China · 8 relevant products
Genomtec S.A.
Poland · 1 relevant product
HealthTec Logix
Kuwait · 2 relevant products
Beijing Jianping Jinxing Biomedical Co., Ltd
China · 1 relevant product
Eone-Diagnomics Genome Center
South Korea · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 2 relevant products
Aliko Scientific SA
France · 2 relevant products
RocGene (Beijing) Technology Co., Ltd.
China · 2 relevant products
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 50 closest product alternatives
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
Guangzhou magigen biotechnology Co.,Ltd · China
Cas9 protein that recognizes and cleaves DNA molecules for gene editing and gene therapy applications. Widely used in molecular diagnostics and genetic engineering.
Guangzhou magigen biotechnology Co.,Ltd · China
High-efficiency CRISPR/Cas12Ultra gene editing tool with independent patent protection for gene therapy applications including CAR-T cell therapy. Advanced molecular diagnostic and therapeutic tool.
Beijing SynsorBio Technology Co., Ltd · China
Single-target CRISPR detection device for point-of-care testing applications. Integrates CRISPR-based molecular detection with microfluidics technology to enable rapid, accurate identification of specific nucleic acid targets in clinical specimens. Designed for decentralized diagnostic workflows requiring minimal infrastructure.
Genomtec S.A. · Poland
An early-stage genetic diagnostic test platform designed for tumor-related genetic analysis and molecular profiling. The product is currently in development for point-of-care oncology applications.
Beijing SynsorBio Technology Co., Ltd · China
A point-of-care testing system utilizing CRISPR technology for rapid nucleic acid detection. The system integrates microfluidics and synthetic biology for accurate identification of genetic sequences in clinical samples.
Intelligenome · United States
IntelliGenome's proprietary CRISPR technology platform for decentralized diagnostics. Accurately detects pathogens and monitors treatment response across multiple applications including TB and oncology.
HealthTec Logix · Kuwait
Comprehensive genomic diagnostic platform providing precision analysis for disease detection and personalized treatment planning. Integrates molecular-based technologies with clinical interpretation for accurate patient stratification.
Beijing Jianping Jinxing Biomedical Co., Ltd · China
A diagnostic kit developed using gene detection technology and molecular biology methods for genomic analysis. Applicable in disease screening and diagnostic evaluation across clinical laboratory settings.
Guangzhou magigen biotechnology Co.,Ltd · China
Cas12a protein with efficient trans-cleavage activity used in combination with isothermal amplification detection techniques for rapid nucleic acid detection. Suitable for molecular diagnostic product development.
Eone-Diagnomics Genome Center · South Korea
Liquid biopsy diagnostic platform for comprehensive genomic analysis and disease screening. Enables detection of genetic markers and abnormalities through blood-based testing.
38 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products